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Background
Major Depressive Disorder (MDD) is a debilitating psy-
chiatric disorder characterized by feelings of low self-
worth, loss of interest and suicidal thoughts. An estimated
350 million people are affected worldwide, 15% being ado-
lescents. Repetitive transcranial magnetic stimulation
(rTMS) is a non-invasive intervention that modulates cor-
tical excitability by inducing electric currents in neurons
by administering pulsating magnetic fields to the scalp.
Studies have shown the left dorsolateral prefrontal cortex
(DLPFC) to be implicated in positive effects on emotion,
and glutamate/Glx levels to be decreased in MDD
patients. In adults, rTMS has been shown to significantly
improve mood, decrease Hamilton Depression Scores and
increase glutamate, glutamine and choline levels in the
DLPFC. We hypothesize an increase in DLPFC glutamate
levels following treatment.
Methods
Eleven treatment-resistant MDD patients (4 females and
7 males, ages 15-21) were recruited and clinically
assessed using the Hamilton Depression/Anxiety Rating
Scale and the Children’s Depression Rating Scale at base-
line, and during each week of treatment for three weeks.
Participants also underwent baseline and post-treatment
MRI scans. Magnetic resonance spectroscopy was used
to measure glutamate levels and data was analysed using
the LC model method. TMS treatments were performed
daily for three weeks and treatment response was defined
as ≥50% decrease in baseline Ham-D rating scale.
Results
In general, rTMS treatments were well tolerated, however
some patients described minor side effects of mild head-
aches and scalp discomfort. Seven patients were treatment
responders who showed symptom improvement, a 62%
decrease in Ham-D scores from 25.43 (±7.85) to 9.57
(±1.51) and a 30% decrease in CDRS scores from 74.43
(±11.04) to 52.14 (±8.99). Ham-A scores decreased 78%
from 23.86 (±9.65) to 5.29 (±3.55). In the left DLPFC,
treatment responder glutamine levels increased by 5% and
Glx levels increased by 10% in the DLPFC. Responders
also showed lower baseline glutamate levels at 8.73 (±1.21)
mmol/kg-wet-weight, which increased by 12% to 9.77
(±1.18) following treatment. Interestingly, non-responders
had higher baseline glutamate levels at 11.87 (±0.47) and
levels decreased by 9% to 10.75 (±0.13).
Conclusions
These findings are consistent with previous literature.
Evidence of increases in excitatory neurotransmitter
levels in the DLPFC and alleviation of symptoms follow-
ing treatment indicate that rTMS exerts anti-depressant
effects and can be pursued as a safe and effective therapy
for adolescent MDD.
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